Published: Sun, December 18, 2016
Economy | By Melissa Porter

Price Target Analysis: Express Scripts Holding Company (NASDAQ:ESRX)

Price Target Analysis: Express Scripts Holding Company (NASDAQ:ESRX)

Oppenheimer Holdings analyst M. Naidu now expects that the firm will earn $1.36 per share for the quarter, down from their previous estimate of $1.38. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its position in shares of Express Scripts Holding by 0.4% in the second quarter.

Several other analysts have also recently issued reports on ESRX. Barrow Hanley Mewhinney & Strauss LLC boosted its position in shares of Express Scripts Holding by 49.9% in the second quarter. The stock was down close to -0.28% on light volume in last trading session and closed at $14.38 per share. The insider owns 410,830 shares as of less than 0.1%, now worth $28421219.4. SRB Corp now owns 2,038 shares of the company's stock worth $144,000 after buying an additional 123 shares in the last quarter. Massachusetts Financial Services Co.

Zacks Investment Research lowered shares of Express Scripts Holding Co. MA now owns 7,768,039 shares of the company's stock valued at $588,818,000 after buying an additional 547,365 shares during the last quarter. Integrated Wealth Management raised its stake in Express Scripts Holding by 4.2% in the second quarter. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $1.78 to $1.90. Heritage Investors Management Corp raised its stake in shares of Express Scripts Holding by 5.5% in the second quarter. Hedge funds and other institutional investors own 84.79% of the company's stock. Express Scripts Holding Company's (ESRX) is a part of Healthcare sector and belongs to Health Care Plans industry. (NYSE:BKD) [Trend Analysis] shows fluctuation in active trade, on Wednesday shares plummeted -3.39% to $11.68. The company has volume of 6.77 Million shares.

Express Scripts, along with CVS Health (CVS) past year also cut Philidor from their networks. The firm has a market capitalization of $42.88 billion, a P/E ratio of 16.44 and a beta of 1.00. Current stock price is in the upbeat territory taking into account of 20 days moving average with -2.70% and continued bullish run for 50 days moving average with -13.62%.

Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 25th.

Ann Hynes, Mizuho Securities analyst, said: "ESRX issued initial 2017 guidance this morning that is relatively in-line with our estimates on all operating metrics including adjusted EPS, adjusted EBITDA, adjusted claims, and free cash flow".

While looking at the Stock's Performance, Express Scripts Holding Company now shows a Weekly Performance of -2.22%, where Monthly Performance is -10.32%, Quarterly performance is -1.47%, 6 Months performance is -7.24% and yearly performance percentage is -20.2%.

In case of Revenue Estimates, 19 analysts have provided their consensus Average Revenue Estimates for Express Scripts Holding Company as 26.3 Billion. The business's revenue for the quarter was up.7% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: This story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. "(ESRX) Stake Maintained by aeris Capital Holding GmbH" was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another website, it was illegally stolen and republished in violation of global trademark & copyright laws. The original version of this story can be accessed at

Express Scripts Holding Company's (ESRX) stock price ended its day with a loss of -1.90% and finalized at the value of $69.18.

According to Zacks Investment Research, WPX Energy, Inc. has a Consensus Recommendation of 1.58. Sanford C. Bernstein restated an underperform rating and set a $59.00 price target on shares of Express Scripts Holding in a report on Thursday, December 1st. They noted that the move was a valuation call.

The Relative Volume of the company is 1.64 and Average Volume (3 months) is 4.14 million.

Express Scripts, one of the largest pharmacy benefit management companies in North America. The job of analysts is to issue recommendations for their clients, and not typically for the general public. They now have a United States dollars 46 price target on the stock.

Like this: